Hypertension and chronic renal failure: The use of ACE inhibitors

American Journal of Kidney Diseases

Volumn 31, Issue 1, 1998, Pages 177-184

  Porush, Jerome G ^a  

^a BROOKDALE UNIVERSITY HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

Angiotension converting enzyme inhibitors; Chronic renal failure; Hypertension

Indexed keywords

ALBUMIN; ANGIOTENSIN; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BENAZEPRIL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; KININ;

BLOOD PRESSURE; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CONFERENCE PAPER; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DISEASE COURSE; ESSENTIAL HYPERTENSION; HUMAN; HYPERTENSION; MEAN ARTERIAL PRESSURE; META ANALYSIS; MORTALITY; RISK FACTOR;

EID: 0031883706     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.1998.v31.pm9428471     Document Type: Conference Paper

References (54)

1. US Renal Data System: USRDS 1994 Annual Data Report. Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 1994
2. Klag MJ, Whelton PJ, Neaton JD, Randall B, Ford CE, Brancati FL, Shulman N, Stambler B: Blood pressure and incidence of ESRD in men: A prospective study. Circulation 89:941, 1994
3. Shulman NB, Ford CE, Hall DW, Blaufox MD, Simon D, Langford HG, Schneider KA, for the Hypertension Detection and Follow-up Program: Prognostic value of serum creatinine and effect of treatment of hypertension on renal function: Results from the Hypertension Detection and Follow-up Program. Hypertension 13:80-93, 1989 (suppl I)
4. Brancati FL, Whelton PK, Whittle JC, Klag MJ: Epidemiologic analysis of existing data to investigate hypertensive renal disease an example from the Maryland End-Stage Renal Disease Registry. Am J Kidney Dis 21:15-24, 1993 (suppl 1)
5. Pemeger TV, Nieto FJ, Whelton PK, Klag MJ, Comstock GW, Szklo M: A prospective study of blood pressure and serum creatinine: Results from the 'Clue' study and the ARIC study. JAMA 269:488-493, 1993
6. Tierney WM, McDonald CJ, Luft FC: Renal disease in hypertensive adults: Effect of race and type II diabetes mellitus. Am J Kidney Dis 13:485-493, 1989
7. Rosansky SJ, Hoover DR, King L, Gibson J: The association of blood pressure levels and change in renal function in hypertensive and nonhypertensive subjects. Arch IM 150:2073-2076, 1990
8. Perry HM, Miller JP, Formoff JR, Baty JD, Sambhi MP, Rutan G, Moskowitz DW, Carmody SE: Early predictors of 15-year end-stage renal disease in hypertensive patients. Hypertension 25:587-594, 1995
9. Lewis EJ, Hunsicker LG, Bain RP, Rhode RD, for the Collaborative Study Group: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 329:1456-1462, 1993
10. Chaiken RL, Palmisario T, Norton ME, Banerji MA, Bard M, Sachimechi I, Behzadi H, Liebowitz HE: Interaction of hypertension and diabetes on renal function in black NIDDM subjects. Kidney Int 47:1697-1702, 1995
11. Ravid M, Savin H, Lang R, Jutrin I, Ludrinovsky S, Lishner M: Proteinuria, renal impairment, metabolic control and blood pressure in type 2 diabetes mellitus. Arch IM 152:1225-1229, 1992
12. Buckolew VM, Berg RL, Porush JG, Rauch S, Schulman G for the Modification of Diet in Renal Disease Study Group: Prevalence of hypertension in 1795 subjects with chronic renal disease: The Modification of Diet in Renal Disease baseline cohort. Am J Kidney Dis 28:811-827, 1996
13. Epstein M, Sowers JR: Diabetes mellitus and hypertension. Hypertension 19:403-418, 1992
14. Chavers BM, Bilous RW, Ellis EN, Steffes MW, Mauer SM: Glomerular lesions and urinary albumin excretion in type I diabetes without overt proteinuria. N Engl J Med 320:966-970, 1989
15. Christensen CK: Abnormal albumin and blood pressure rise in incipient diabetic nephropathy induced by exercise. Kidney Int 25:819-823, 1984
16. Baldwin DS, Neugarten J: Blood pressure control and progression of renal insufficiency, in Brenner BM, Stein JH (eds): Contemporary Issues in Nephrology. New York, NY, Churchill Livingstone, 1986, pp 81-110
17. Bergstrom J, Alverstrand A, Bucht H, Guitierrez A: Stockholm clinical study on progression of chronic renal failure: An interim report. Kidney Int 27:110-114, 1989
18. Brazy PC, Stead WW, Fitzwilliam JF: Progression of renal insufficiency: Role of blood pressure. Kidney Int 35:670-674, 1989
19. Hasselacher C, Stech W, Ritz E: Blood pressure and metabolic control as risk factors for nephropathy in type I (insulin-dependent) diabetes. Diabetologia 28:6-11, 1985
20. Maschio G, Oldrizzi L, Rugiu C, Valvo E, Lupo A, Loschiavo C, Tessitore N, Fabris A, Gammaro L, Pomzetta G: Factor affecting progression of renal failure in patients on long-term dieting protein restriction. Kidney Int 22: S49-S52, 1987 (suppl)
21. Steinvenkel P, Alvestrand A, Bergstiöm J: Factor influencing progression in patients with chronic renal failure. J Intern Med 226:183-188, 1989
22. Bergstiöm J, Alvestrand A, Bucht H, Guitierrez A: Stockholm clinical study on progression of chronic renal failure: An interim report. Kidney Int 36: S110-S114, 1989 (suppl)
23. Walker GW, Neaton JD, Cutler JA, Neuwirth R, Cohen JD, for the MRFIT Research Group: Renal function change in hypertensive members of the Multiple Risk Factor Intervention Trial: Racial and treatment effects. JAMA 268:3085-3091, 1992
24. Rostand SG, Brown G, Kirk KA, Rustky EA, Dustan HP: Renal insufficiency in treated essential hypertension. N Engl J Med 320:684-688, 1989
25. Madhaven S, Stockwell D, Cohen H, Alderman MH: Renal function during antihypertension treatment. Lancet 345:749-751, 1995
26. Toto RD, Mitchell HC, Smith RD, Lee HC, McIntire D, Pettinger WA: "Strict" blood pressure control and progression of renal disease in hypertensive nephrosclerosis. Kidney Int 48:851-859, 1995
27. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure: Fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch IM 153:541-183, 1993
28. Modification of Diet in Renal Disease Study Group: The Modification of Diet in Renal Disease Study: Design, methods, and results from the feasibility study. Am J Kidney Dis 20:18-33, 1992
29. Wright JP, Brown CB, El Nahas AM: Effect of control on hypertension on progressive renal failure. Clin Nephrol 39:305-311, 1993
30. Alvestrand A, Guiterrez AM, Bucht H, Bergström J: Reduction of blood pressure retards the progression of chronic renal failure in man. Nephrol Dial Transplant 3:624-631, 1988
31. Klahr S, Levey AS, Beck GJ, Caggivla AW, Hunsicker L, Kusek JW, Striker G, for the Modification of Diet in Renal Disease Study Group: The effects of dietary protein restriction and blood pressure control on the progression of chronic renal disease. N Engl J Med 330:877-884, 1994
32. Klahr S: Role of dietary protein and blood pressure in the progression of renal disease. Kidney Int 49:1783-1786, 1996
33. Bergström J, Alvestrand A, Bucht M, Guiterrez A: Progression of chronic renal failure in man is retarded with more frequent clinical follow-ups and better blood pressure control. Clin Nephrol 25:1-6, 1986
34. Zucchelli P, Zuccalà A, Borghi M, Fusaroli M, Sasdelli M, Stallone C, Sanna G, Gaggi R: Long-term comparison between captopril and nifedipine in the progression of renal insufficiency. Kidney Int 42:452-458, 1992
35. Dillion JJ: The quantitative relationship between treated blood pressure and progression of diabetic renal disease. Am J Kidney Dis 22:798-802, 1993
36. Walker WG: Hypertension-related renal injury: A major contributor to end-stage renal disease. Am J Kidney Dis 22:164-173, 1993
37. Parving H-H, Smidt UM, Hommel E, Mathiesen ER, Rossing P, Nielson F, Gall MA: Effective antihypertensive treatment postpones renal insufficiency in diabetic nephropathy. Am J Kidney Dis 22:188-195, 1993
38. Herbert LA, Bain RP, Verne D, Cottran D, Whittier FC, Tolchin N, Rhode RD, Lewis ES, for the Collaborative Study Group: Remission of nephrotic range proteinuria in type 1 diabetes. Kidney Int 46:1688-1693, 1994
39. Klahr S, Breyer JA, Beck GJ, Kimberly WJ, Dobin A, Gabow PA, for the Modification of Diet in Renal Disease Study Group: Dietary protein restriction, blood pressure control, and the progression of polycystic kidney disease. J Am Soc Nephrol 5:2032-2047, 1995
40. Wolf G, Ziyadeh FN: The role of angiotensin II in diabetic nephropathy: Emphases on nonhemodynamic mechanisms. Am J Kidney Dis 29:153-163, 1997
41. Hannedouche T, Landais P, Goldfarb B, Esper NE, Fournier A, Galin M, Durand D, Chanard J, Mignon F, Suc J-M, Grünfeld J-P: Randomized controlled trial of enalapril and β-blockers in non-diabetic chronic renal failure. BMJ 309:833-837, 1994
42. Maschio G, Alberti D, Jonin G, Locatelli F, Mann JFE, Motolese M, Ponticelli C, Ritz E, Zucchelli P: Effects of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. N Engl J Med 334:939-945, 1996
43. Kasiske BL, Kalil RSN, Ma JZ, Liao M, Keane WM: Effects of antihypertensive therapy on the kidney in patients with diabetes: A meta-regression analysis. Ann IM 118:129-138, 1993
44. UM, Parving H-H: Impact of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy. Diabetes 43:1108-1113, 1994
45. Lacourciére Y, Nadeau A, Poirier L, Tancréde G: Captopril or conventional therapy in hypertensive type II diabetics: Three-year analysis. Hypertension 21:786-794, 1993
46. Liou H-H, Huang T-p, Campese VM: Effect of long-term therapy with captopril on proteinuria and renal function in patients with non-insulin dependent diabetes and with non-diabetic renal disease. Nephron 69:41-48, 1995
47. Mathiesen ER, Hommel E, Giese J, Parving H-H: Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria. BMJ 303:81-87, 1991
48. Dougall ML, Moore WV: Effect of angiotensin-converting enzyme inhibition on renal function and albuminuria in normotensive type I diabetic patients. Diabetes 41:62-67, 1992
49. Ravid M, Savin H, Jutrin I, Dental T, Lishner M: Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients. Ann IM 118:577-581, 1993
50. Romero R, Salinas I, Lucas A, et al: Renal function changes in microalbuminuric normotensive type II diabetic patients treated with angiotensin-converting enzyme inhibitors. Diabetes Care 16:597-600, 1993
51. Viberti G, Mogensen CE, Groop LC, et al: Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. JAMA 271:275-279, 1994
52. Bakris GL, Barnhill BW, Sadler R: Treatment of arterial hypertension in diabetic humans: Importance of therapeutic selection. Kidney Int 41:912-919, 1992
53. Slataper R, Vicknair N, Sadler R, Bakris GL: Comparative effects of different antihypertensive treatments on progression of diabetic kidney disease. Arch Intern Med 153:973-980, 1993
54. Zoja C, Biolsci D, Donadelli R, et al: The renoprotective properties of angiotensin-converting enzyme inhibitors in a chronic model of membranous nephropathy are solely due to the inhibition of angiotensin II: Evidence based on comparative studies with a receptor antagonist. Am J Kidney Dis 29:254-264, 1997